News from Cepheid A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Oct 27, 2016, 08:00 ET 30 Minute Or Less Molecular Flu/RSV Test Now Available Outside The US

With the flu season fast approaching, healthcare providers no longer need to choose between a fast test result or an accurate test result for...


Oct 24, 2016, 08:00 ET Cepheid Announces Receipt of Required Regulatory Clearances in Proposed Acquisition by Danaher Corporation

Cepheid (NASDAQ: CPHD) today announced that antitrust clearances have been received or the requisite waiting periods have expired, as applicable,...


Oct 05, 2016, 16:05 ET New Bladder Cancer Test Could Reduce Number Of Invasive Procedures Required For Recurrence Monitoring

 There's now an easier way to confidently rule out bladder cancer recurrence, thanks to a new test from Cepheid (Nasdaq: CPHD), Xpert®...


Sep 15, 2016, 16:05 ET Cepheid Announces Expansion Of The Most Comprehensive Molecular C. Difficile Product Portfolio On The Market

 Particularly perilous Clostridium difficile strains are now potentially easier to detect, thanks to expanded reporting  of binary toxin...


Sep 08, 2016, 16:05 ET Cepheid Targets Development of a Point of Care HIV Viral Load Test From a Few Drops of Blood

 Millions of patients, including newborns, in primary health care settings could gain access to a potentially life-changing test for HIV viral...


Sep 06, 2016, 16:15 ET Cepheid's Xpert TV Now Cleared For Testing Symptomatic And Asymptomatic Men

Men in the United States can now have easier access to fast and accurate testing for a potentially dangerous sexually transmitted infection, thanks...


Sep 06, 2016, 06:30 ET Cepheid Agrees To Be Acquired By Danaher Corporation For $53 Per Share In Cash

 Cepheid (NASDAQ: CPHD) today announced that it has entered into a definitive agreement with Danaher Corporation (NYSE: DHR) under which...


Aug 04, 2016, 16:05 ET Cepheid to Webcast Upcoming Financial Presentations

Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via...


Jul 28, 2016, 16:05 ET Cepheid Reports Second Quarter 2016 Results

 Cepheid (Nasdaq: CPHD) today reported revenue for the second quarter of 2016 of $146.0 million, representing growth of 10%, or 12% on a...


Jul 12, 2016, 08:00 ET Cepheid Announces Results Of Validation Study For Use Of Xpert HPV In Primary Cervical Cancer Screening

Cepheid (Nasdaq: CPHD) today announced the publication of a validation study assessing the use of Xpert HPV (Human Papillomavirus) as a front-line...


Jul 07, 2016, 16:05 ET Cepheid Schedules 2016 Second Quarter Results Announcement And Webcast

 Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2016 second quarter on Thursday, July 28, 2016, after the...


Jun 30, 2016, 08:00 ET FDA Supports Expanded Claims for Xpert Carba-R Test for "Superbugs"

SUNNYVALE, Calif., June 30, 2016 /PRNewswire/-- Cepheid (Nasdaq: CPHD) today announced that it has received clearance from the U.S. Food and Drug...


May 05, 2016, 08:00 ET US National TB Controllers Association And Association Of Public Health Laboratories Issue Guidance For Use Of Xpert MTB/RIF To Support Respiratory Isolation Decisions

Cepheid (Nasdaq: CPHD) today welcomed publication of new guidance from the US National Tuberculosis Controllers Association (NTCA) and the...


May 03, 2016, 08:00 ET Cepheid to Webcast Upcoming Financial Presentations

Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via...


Apr 28, 2016, 16:05 ET Cepheid Reports First Quarter 2016 Results

 Cepheid (Nasdaq: CPHD) today reported revenue for the first quarter of 2016 of $144.8 million, representing growth of 9%, or 13% on a constant...


Mar 24, 2016, 08:00 ET Cepheid Recognizes World TB Day 2016 With Delivery Of 5,000th GeneXpert System To Support Global Fight Against Tuberculosis And Multi-Drug Resistant Tuberculosis

 Cepheid (Nasdaq: CPHD) today recognized World TB Day 2016 with the delivery of the 5,000th GeneXpert® System to be deployed as part of...


Mar 09, 2016, 08:00 ET Cepheid Announces First FDA-Cleared Test for Detection of Carbapenem Resistance Genes in Isolates of Multidrug Resistant 'Superbugs'

 Cepheid (Nasdaq: CPHD) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market Xpert®...


Mar 07, 2016, 08:00 ET Cepheid Delivers Milestone 10,000th GeneXpert System

Cepheid (Nasdaq: CPHD) today announced the delivery of the 10,000th GeneXpert® System to the 10 Hammersmith Broadway Clinic in London,...


Feb 10, 2016, 16:05 ET Cepheid Announces Appointment of President and Chief Operating Officer and Welcomes Executive Vice President of Engineering and Operations

 Cepheid (Nasdaq: CPHD) today announced that Warren Kocmond, formerly Executive Vice President and Chief Operating Officer, has been promoted...


Feb 03, 2016, 16:05 ET Cepheid to Webcast Upcoming Financial Presentations

Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via...


Feb 02, 2016, 16:02 ET Cepheid Reports Fourth Quarter And Full Year 2015 Results

Cepheid (Nasdaq: CPHD) today reported revenue for the fourth quarter of 2015 of $147.0 million, representing growth of 12% from $131.5 million for...


Jan 13, 2016, 16:05 ET Cepheid Announces Diagnostic Collaboration With MedImmune And COMBACTE To Facilitate Clinical Trials Of New Monoclonal Antibodies To Prevent Serious Infectious Diseases

 Cepheid (Nasdaq: CPHD) today announced a collaboration with MedImmune, the global biologics research and development arm of AstraZeneca, and...


Jan 11, 2016, 08:00 ET Cepheid Schedules 2015 Fourth Quarter And Full Year Results Announcement And Webcast

 Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2015 fourth quarter and full year ended December 31, 2015...


Jan 07, 2016, 08:00 ET USAID And Cepheid Plan Collaboration To Accelerate Global Diagnosis Of Multidrug-Resistant Tuberculosis

 Cepheid (NASDAQ: CPHD) today announced that it has signed a Memorandum of Understanding (MOU) representing the intention of the company,...


Jan 05, 2016, 08:00 ET Cepheid to Webcast Upcoming Financial Presentations

 Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate...